$26.60
-0.06-0.23%
Ult. Agg.: Nov 12, 9:26 AM
Surgery Partners rose 68.1% from $15.86 to $26.66, ahead of the S&P 500's +11.2%. Its worst day was Mar 3 (−12.3%), and its low came Mar 27 at $11.49.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.12 missed the $0.29 estimate on $885.0M revenue (est. $869.3M); FY revenue guidance of $3.4B–$3.5B against the $3.5B consensus.
−12.3%, the year's worst day · S&P 500 −0.9%
Story events cover the past 12 months · Times ET
Surgery Partners closed at its lowest level of the year, 27.6% below where the year started.
−3.0% · S&P 500 −1.7%
EPS of $-0.03 beat the $-0.14 estimate on $810.9M revenue (est. $798.1M); FY revenue guidance of $3.4B–$3.5B against the $3.4B consensus.
+0.4% · S&P 500 +0.8%
EPS of $0.10 beat the $0.05 estimate on $848.9M revenue (est. $831.3M); FY revenue guidance of $3.4B–$3.5B against the $3.4B consensus.
+2.7% · S&P 500 0.0%
Surgery Partners shares rose 15.7%, while the S&P 500 fell 0.0%.
+15.7% · S&P 500 0.0%
Surgery Partners shares rose 47.6%, while the S&P 500 rose 0.7%.
+47.6%, the year's best day, on 59M shares, the year's heaviest volume · S&P 500 +0.7%
EPS of $0.16 beat the $0.07 estimate on $815.3M revenue (est. $815.3M).
+1.1% · S&P 500 −0.4%
Where it ended: a close of $26.66 on Nov 11, 2026. Up next: Q4 2026 earnings on Mar 1, 2027 (EPS est. $0.06, revenue est. $711.6M).
Nothing in the past 12 months.
All SGRY dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SGRY and SPY from Benzinga historical bars. Not investment advice.